Funding Opportunity RFA-AG-24-046 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) aims toprovide a proof-of-principle for a novel strategy for Alzheimer Disease and Alzheimer Related Dementias (AD/ADRD) immunotherapies. Specifically, the goal is to examine if a novel immunotherapeutic approach in cancer immunotherapy with Chimeric Antigen Receptor (CAR) immune cellscould be customized as treatments for AD/ADRD. This NOFO utilizes the R61/R33Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities.

Notice NOT-CA-23-081 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-23-290 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to invite proposals focused on developing strategies and interventions to improve diagnostic safety in the heterogenous ambulatory care environment. AHRQ is interested in providing support designed to develop, test, and evaluate ambulatory care activities that will improve diagnostic safety and quality.

Notice NOT-DK-23-030 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-23-263 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Funding Opportunity PA-23-291 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to invite proposals focused on understanding and improving diagnostic safety in the heterogenous ambulatory care environment. AHRQ is interested in learning the incidence and contributory factors of diagnostic error within and across the array of ambulatory care services.

Competitive + Benefits: BIOTRIAL: As Prinicipal Biostatistician, you will be able to manage all statistical aspects of Phase I to IV studies in various therapeutic areas Rennes, Nantes, Mulhouse, Newark (USA), Laval (Canada) or homebased.

Competitive Salary: Lonza: United Kingdom, Slough Today, Lonza is a global leader in life sciences operating across three continents. While we work in science, there's no mag... Slough, United Kingdom

Competitive Salary: Lonza: United Kingdom, Cambridge Today, Lonza is a global leader in life sciences operating across three continents. While we work in science, there's no ... Cambridge, United Kingdom

Competitive Salary: Lonza: United Kingdom, Cambridge Today, Lonza is a global leader in life sciences operating across three continents. While we work in science, there's no ... Cambridge, United Kingdom

Competitive Salary: Lonza: United Kingdom, Cambridge Senior / Lead Scientist   Today, Lonza is a global leader in life sciences operating across three continents. While we wo... Cambridge, United Kingdom

; high-throughput techniques in genomics, such as RNA-seq; microscopy, specifically confocal microscopy; work with research animal models; and bioinformatics…
From University of Wyoming - Mon, 21 Aug 2023 20:14:21 GMT - View all Laramie, WY jobs

Notice NOT-DA-25-025 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-24-069 from the NIH Guide for Grants and Contracts. The intersection of criminal-legal and community-based health systems is a critical target for addressing the overdose crisis. To support research on effective interventions and implementation strategies, the National Institute on Drug Abuse intends to continue the Justice Community Overdose Innovation Network (JCOIN) Phase II. The purpose of the network is to bring together a national consortium of investigators and practitioner partners to conduct an array of research and capacity building activities to address the overdose epidemic among individuals involved in the criminal-legal system. The structure of the network shall consist of three highly integrated components - (1) Research Hubs; (2) a single, central Coordination and Translation Center; and (3) a single, central Methodology and Advanced Analytics Resource Center. This NOFO solicits applications for a Coordination and Translation Center. This NOFO runs in parallel with a companion NOFO for the Methodology and Advanced Analytics Resource Center (NOT-DA-24-068); a NOFO for Research Hubs is anticipated at a future date (NOT-DA-25-025).

Funding Opportunity RFA-DA-24-068 from the NIH Guide for Grants and Contracts. The intersection of justice and community-based health systems is a critical target for addressing the opioid crisis. The National Institute on Drug Abuse intends to establish the Justice Community Overdose Innovation Network (JCOIN) using the cooperative agreement mechanism. The purpose of the network is to establish a national consortium of investigators examining promising interventions and other approaches that can improve the capacity of the justice system to effectively respond to the opioid epidemic. The structure of the network shall consist of three highly integrated components - (1) Clinical Research Centers (each center will propose a study to be executed in at least 5 research performance sites); (2) a single, central Coordination and Translation Center; and (3) a single, central Methodology and Advanced Analytics Resource Center. This FOA solicits applications for a Methodology and Advanced Analytics Resource Center. This FOA runs in parallel with companion FOAs that seek applications for Clinical Research Centers (RFA-DA-19-025), and a single Coordination and Translation Center (RFA-DA-19-024).

Notice NOT-CA-23-084 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-018 from the NIH Guide for Grants and Contracts. The goal of this concept is to support exploratory research and preliminary interventions to address the interrelated and compounding contextual factors that contribute to substance use and HIV risk among sexual trafficking survivors. This would be accomplished through research that builds new interventions and models of care that can effectively engage ST survivors in care for SUD, HIV, trauma, and other mental health outcomes and addresses key structural and social determinants of health that contribute to risk for ST as well as barriers to and facilitators of escaping continued exploitation.

Notice NOT-EB-23-016 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-086 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-053 from the NIH Guide for Grants and Contracts